Azitra Inc (AZTR)

$0.22 +0.01 (3.33%)
Market Cap 3.45M
Revenue (ttm) 0.00
Net Income (ttm) -10.96M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 436,600
Avg Vol 14,890,492
Day's Range N/A - N/A
Shares Out 16.19M
Stochastic %K 70%
Beta -2.17
Analysts Strong Sell
Price Target $1.35

Company Profile

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically m...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 646 6446
Address:
21 Business Park Drive, Branford, United States
mystic_13
mystic_13 Apr. 23 at 7:18 PM
$AZTR
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Apr. 22 at 11:22 PM
$AZTR patent
0 · Reply
mystic_13
mystic_13 Apr. 22 at 10:38 PM
$AZTR
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 22 at 7:34 PM
$AZTR RSI: 26.90, MACD: -0.0008 Vol: 0.01, MA20: 0.23, MA50: 0.21 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
mystic_13
mystic_13 Apr. 22 at 11:58 AM
$AZTR
0 · Reply
luminouslumens
luminouslumens Apr. 21 at 11:49 PM
$AZTR 🧐
0 · Reply
mystic_13
mystic_13 Apr. 21 at 8:14 PM
$AZTR
0 · Reply
US_Patent_Plays
US_Patent_Plays Apr. 21 at 7:58 PM
$AZTR Nasdaq Penny Stock Granted US Patent #12606610 Today for "COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES". https://ppubs.uspto.gov/pubwebapp/external.html?q=(12606610).pn
0 · Reply
TangibleOne
TangibleOne Apr. 21 at 1:42 AM
$AZTR Long here and SKM (ticker) for the Anthropic pre IPO exposure
0 · Reply
MikiTrader
MikiTrader Apr. 13 at 2:34 PM
$AZTR Take it easy and bring the stock back to normal.
0 · Reply
Latest News on AZTR
Why Are Shares Of Azitra Rising?

Mar 20, 2026, 1:09 PM EDT - 5 weeks ago

Why Are Shares Of Azitra Rising?

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Mar 19, 2026, 1:13 PM EDT - 5 weeks ago

Azitra Announces Pricing of Private Placement Financing of up to Approximately $10.5 Million with up to an Additional Approximately $20.9 Million

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Mar 13, 2026, 5:15 PM EDT - 6 weeks ago

Azitra Receives Notice of Non-Compliance from NYSE American and Makes NYSE American Section 610(b) Public Announcement

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Mar 5, 2026, 4:30 PM EST - 7 weeks ago

Azitra, Inc. Announces Cancellation of 2026 Special Meeting of Stockholders

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Feb 27, 2026, 5:30 PM EST - 2 months ago

Azitra, Inc. Announces Full Year 2025 Results and Provides Business Updates

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Feb 24, 2026, 8:00 AM EST - 2 months ago

Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash

Azitra, Inc. to Present at BIO Investment & Growth Summit

Feb 19, 2026, 8:00 AM EST - 2 months ago

Azitra, Inc. to Present at BIO Investment & Growth Summit

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Feb 6, 2026, 4:15 PM EST - 2 months ago

Azitra Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 3 months ago

Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Dec 17, 2025, 4:10 PM EST - 4 months ago

Azitra Receives Notice of Acceptance of the Listing Standards Compliance Plan from NYSE American

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Nov 24, 2025, 9:00 AM EST - 5 months ago

Azitra, Inc. Announces Pricing of $1.5 Million Private Placement Priced At a Premium To Market Under NYSE Rules

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Nov 12, 2025, 5:15 PM EST - 5 months ago

Azitra, Inc. Announces Q3 2025 Results and Provides Business Updates

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Nov 7, 2025, 6:00 AM EST - 6 months ago

Azitra, Inc. Addresses False Report Regarding Sale of Securities

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Oct 20, 2025, 8:02 AM EDT - 6 months ago

Azitra, Inc. Announces Positive Preclinical Data for ATR-01 Program, Designed to Treat Ichthyosis Vulgaris

Azitra Receives Notice of Non-Compliance from NYSE American

Oct 3, 2025, 4:45 PM EDT - 7 months ago

Azitra Receives Notice of Non-Compliance from NYSE American

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 4, 2025, 8:10 AM EDT - 8 months ago

Azitra, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Aug 27, 2025, 8:10 AM EDT - 8 months ago

Azitra, Inc. Announces First Patient Dosed in Phase 1/2 Trial for ATR-04 Program Targeting Oncology Patients with EGFRi-Associated Rash

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

Aug 22, 2025, 6:01 AM EDT - 8 months ago

Stock Market Today: Nasdaq, Dow, S&P 500 Futures Rise Ahead Of Powell's Speech At Jackson Hole—EpicQuest, Zoom, Azitra Stocks In Focus

IVV SPXL SPY SSO UPRO VOO ZM

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Aug 11, 2025, 5:00 PM EDT - 9 months ago

Azitra, Inc. Announces Q2 2025 Results and Provides Business Updates

Azitra, Inc. Announces Reverse Stock Split

Aug 11, 2025, 4:15 PM EDT - 9 months ago

Azitra, Inc. Announces Reverse Stock Split

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Jun 17, 2025, 8:02 AM EDT - 11 months ago

Azitra Reports Promising Safety Data from Phase 1b Trial in Netherton Syndrome

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Jun 10, 2025, 8:33 AM EDT - 11 months ago

Azitra, Inc. Announces Presentation at the 2025 BIO International Convention

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

May 28, 2025, 8:33 AM EDT - 11 months ago

Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

May 14, 2025, 4:05 PM EDT - 1 year ago

Azitra, Inc. to Present Abstract at American Society of Gene and Cell Therapy Highlighting Phase 1/2 Study Targeting Cancer Therapy-Associated Rash

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

May 13, 2025, 5:06 PM EDT - 1 year ago

Azitra, Inc. Announces Q1 2025 Results and Provides Business Updates

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Apr 25, 2025, 8:33 AM EDT - 1 year ago

Azitra, Inc. to Present ATR-04 Program Update at ASCO 2025

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Apr 24, 2025, 4:05 PM EDT - 1 year ago

Azitra Announces Share Purchase Agreement for up to $20 Million in Partnership with Alumni Capital to Fund Clinical Pipeline

Azitra to Present at Microbiome Times Partnering Forum

Mar 12, 2025, 8:33 AM EDT - 1 year ago

Azitra to Present at Microbiome Times Partnering Forum

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Feb 24, 2025, 8:30 AM EST - 1 year ago

Azitra, Inc. Announces Full Year 2024 Financial Results and Provides Business Updates

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Feb 4, 2025, 2:20 PM EST - 1 year ago

Azitra Announces Pricing of $930.0 Thousand Registered Direct Offering of Common Stock

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Feb 3, 2025, 9:05 AM EST - 1 year ago

Azitra, Inc. to Present at the BIO CEO & Investor Conference

Azitra, Inc. to Present at The Microcap Conference

Jan 27, 2025, 4:05 PM EST - 1 year ago

Azitra, Inc. to Present at The Microcap Conference

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Jan 15, 2025, 8:30 AM EST - 1 year ago

Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock

Azitra Announces Proposed Public Offering of Common Stock

Jan 14, 2025, 4:05 PM EST - 1 year ago

Azitra Announces Proposed Public Offering of Common Stock

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Nov 12, 2024, 5:05 PM EST - 1 year ago

Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates

Azitra to Present at BIO-Europe 2024

Oct 29, 2024, 9:00 AM EDT - 1 year ago

Azitra to Present at BIO-Europe 2024

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Oct 11, 2024, 9:00 AM EDT - 1 year ago

Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Sep 18, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 6, 2024, 4:30 PM EDT - 1 year ago

Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 28, 2024, 8:30 AM EDT - 1 year ago

Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Aug 22, 2024, 9:00 AM EDT - 1 year ago

Azitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR Inhibitors

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Aug 20, 2024, 4:15 PM EDT - 1 year ago

Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

Aug 12, 2024, 6:23 PM EDT - 1 year ago

Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

Jul 25, 2024, 5:57 PM EDT - 1 year ago

CORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public Offering

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

Jul 25, 2024, 1:54 PM EDT - 1 year ago

You.com Announces Strategic Collaboration With Moesif to Drive Productivity and Power Usage-Based Billing

HAL

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

Jul 25, 2024, 1:13 PM EDT - 1 year ago

Wingspire Equipment Finance's $12 Million Funding Initiative to Propel Tier 1 Aerospace Manufacturer Capabilities

HAL

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Jul 23, 2024, 9:20 PM EDT - 1 year ago

Azitra, Inc. Announces Pricing of $10.0 Million Public Offering

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Jul 23, 2024, 8:00 AM EDT - 1 year ago

Azitra, Inc. Strengthens Global Intellectual Property Portfolio with Newly Granted and Allowed Patents

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

May 31, 2024, 8:00 AM EDT - 2 years ago

Azitra, Inc. Announces Presentation at the 2024 BIO International Convention

mystic_13
mystic_13 Apr. 23 at 7:18 PM
$AZTR
0 · Reply
DisneyPalaceTrades
DisneyPalaceTrades Apr. 22 at 11:22 PM
$AZTR patent
0 · Reply
mystic_13
mystic_13 Apr. 22 at 10:38 PM
$AZTR
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 22 at 7:34 PM
$AZTR RSI: 26.90, MACD: -0.0008 Vol: 0.01, MA20: 0.23, MA50: 0.21 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
mystic_13
mystic_13 Apr. 22 at 11:58 AM
$AZTR
0 · Reply
luminouslumens
luminouslumens Apr. 21 at 11:49 PM
$AZTR 🧐
0 · Reply
mystic_13
mystic_13 Apr. 21 at 8:14 PM
$AZTR
0 · Reply
US_Patent_Plays
US_Patent_Plays Apr. 21 at 7:58 PM
$AZTR Nasdaq Penny Stock Granted US Patent #12606610 Today for "COMPOSITIONS AND METHODS FOR TREATMENT OF NETHERTON SYNDROME WITH LEKTI EXPRESSING RECOMBINANT MICROBES". https://ppubs.uspto.gov/pubwebapp/external.html?q=(12606610).pn
0 · Reply
TangibleOne
TangibleOne Apr. 21 at 1:42 AM
$AZTR Long here and SKM (ticker) for the Anthropic pre IPO exposure
0 · Reply
MikiTrader
MikiTrader Apr. 13 at 2:34 PM
$AZTR Take it easy and bring the stock back to normal.
0 · Reply
MikiTrader
MikiTrader Apr. 13 at 2:29 PM
$AZTR Indeed.
0 · Reply
TheOne_24
TheOne_24 Apr. 10 at 1:17 PM
$WGRX $MOBX $AZTR $GPUS Come to $WGRX .45 possible. Shits about to hit the fan
0 · Reply
GenX_Forever_Feral
GenX_Forever_Feral Apr. 10 at 3:01 AM
$AZTR I AGREE. BETTER TO BE EARLY THAN CHASE IT. The CEO went in for millions. DUH. Everybody is MISSING IT.
0 · Reply
kfuman1
kfuman1 Apr. 8 at 11:19 PM
$AZTR lol computer program likes to draw pictures, but STILL keeps it at .23
0 · Reply
TradingWithJoy
TradingWithJoy Apr. 8 at 3:20 PM
$AZTR Nibbling here. Liking the fact CEO put up.
1 · Reply
luminouslumens
luminouslumens Apr. 8 at 2:40 PM
$AZTR 🧐🧐
0 · Reply
kfuman1
kfuman1 Apr. 7 at 1:43 PM
$AZTR The powers that be want this to stay at 23 it seems...
0 · Reply
TheOne_24
TheOne_24 Apr. 7 at 10:44 AM
$AZTR $EONR $HCAI $MOBX $TPET
0 · Reply
GenX_Forever_Feral
GenX_Forever_Feral Apr. 6 at 9:00 PM
$AZTR
0 · Reply
MikiTrader
MikiTrader Apr. 4 at 5:01 AM
$AZTR too heavy
0 · Reply
Louie2025
Louie2025 Apr. 1 at 2:51 PM
$AZTR why would a person suppress this ? look at 2900 are both sides
1 · Reply
WienersOut4RCAT
WienersOut4RCAT Apr. 1 at 2:39 AM
$OPTT $TPET $MOBX $AZTR $CXAI
0 · Reply